Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Hi-Tech Hunts Growth As FTC Picks Up Scent On Disputed Weight Loss Claims

This article was originally published in The Tan Sheet

Executive Summary

FTC asks a federal court to re-instate a contempt order stemming from Hi-Tech Pharmaceuticals’ misleading claims for weight loss supplements that an appellate court overturned. Hi-Tech, meanwhile, argues for recusal of the judge who found the firm in contempt and ordered two executives to jail.


Related Content

Hi-Tech Avoids FTC Contempt Charge, But Not The Judge
Industry News: Twinlab Into Resveratrol, Hi-Tech Buys LG Brands
Industry Roundup: FDA Inspecting McNeil Plants, Hi-Tech Gets Another Chance Against FTC
Hi-Tech Pharmaceuticals Indicted For Online “Generic” Drug Enterprise